Document Detail


Protective effects of enalapril in streptozotocin-induced diabetic rat: studies of DNA damage, apoptosis and expression of CCN2 in the heart, kidney and liver.
MedLine Citation:
PMID:  21416479     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Diabetes mellitus is characterized by hyperglycemia, which induces oxidative stress and perturbs a number of pathways, leading to tissue injury. One of the pathological responses to tissue injury is the development of fibrosis and cell death. Enalapril is a non-thiol angiotensin-converting enzyme inhibitor that is commonly used in the treatment of diabetes-associated hypertension. The present study examines the possible beneficial effects of enalapril on the development of diabetes associated fibrosis and DNA damage in rats. Sprague-Dawley rats (250 ± 10 g) were used in the study. Enalapril (10 mg kg(-1) per oral) was administered for four consecutive weeks to the streptozotocin (STZ)-induced diabetic rats. After 4 weeks, all the animals were sacrificed and comet assay (normal and modified) was performed to detect the normal as well as oxidative DNA damage. Expression of profibrotic marker CCN2 and fibrosis was examined in the heart, kidney and liver of diabetic rats. Enalapril treatment significantly restored the malondialdehyde and glutathione content as well as the DNA damage in the heart, kidney and liver of diabetic rat. Significant decrease in the expression of CCN2 was observed in the heart, kidney and liver of diabetic rat receiving enalapril treatment as compared with the diabetic group. Further, the enalapril treatment led to significant decrease in the fibrosis and CCN2 expression in the diabetic group as compared with control. The results of the present study clearly demonstrate that enalapril ameliorates the DNA damage, cell death and expression of CCN2 in the heart, kidney and liver of the STZ-induced diabetic rat. Copyright © 2011 John Wiley & Sons, Ltd.
Authors:
S Kushwaha; A Vikram; G B Jena
Related Documents :
16389649 - Plasma apolipoprotein e concentration is an important determinant of phospholipid trans...
17970759 - Effects of combined ppargamma and pparalpha agonist therapy on reverse cholesterol tran...
6680539 - Incidence of hyperlipemia in diabetics in okinawa and its relation to ischemic heart di...
18684539 - Apolipoprotein b and insulin resistance are good markers of carotid atherosclerosis in ...
15748599 - Relationship between plasma lipid concentrations and hdl subclasses.
7698509 - Correction of hypertriglyceridemia with low high-density lipoprotein cholesterol by the...
4076389 - Trypanosoma brucei: infection in murine diabetes.
6732579 - Clearance from the anterior chamber of rbcs from human diabetics.
11874429 - Impact of poverty on the prevalence of diabetes and its complications in urban southern...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-3-18
Journal Detail:
Title:  Journal of applied toxicology : JAT     Volume:  -     ISSN:  1099-1263     ISO Abbreviation:  -     Publication Date:  2011 Mar 
Date Detail:
Created Date:  2011-3-18     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8109495     Medline TA:  J Appl Toxicol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 John Wiley & Sons, Ltd.
Affiliation:
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Sector-67, S.A.S. Nagar, Punjab, 160062, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vitro toxicity of aflatoxin B(1) and its photodegradation products in HepG2 cells.
Next Document:  Dietary vitamin C and E modulates oxidative stress induced-kidney and lens injury in diabetic aged m...